A recent breakthrough in pharmaceutical research has seen the acceleration of drug development processes thanks to an innovative integration of proprietary databases using a unified knowledge graph created with Amazon Web Services' (AWS) GraphRAG.
Historically, the initial stages of a project involving data gathering and screening phases took over six months per iteration. This resulted in a low five percent success rate, making it nearly impossible for new drugs to be developed and approved on time. In contrast, the newly deployed system has enabled researchers to gather and integrate all necessary data in just a matter of weeks.
The integration process involved combining previously separated proprietary databases into a single unified knowledge graph that is now queryable by AI algorithms. This allows researchers to quickly identify potential leads, reduce trial failures, and increase the chances of successful drug development. By streamlining these critical processes, pharmaceutical companies can significantly reduce their time-to-market for new treatments, ultimately benefiting patients.